In order to evaluate whether UBE4B protein expression was correlated with any other known neuroblastoma prognostic factors, UBE4B staining intensity was compared in patient cohorts divided by tumor stage, treatment risk group, MYCN amplification, Shimada histology, and patient age at diagnosis. The gene discussed is MYCN; the disease is neuroblastoma.